资讯

contemporarypediatrics19 小时
Gena Schubert, D.O.
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics19 小时
Kaysi Krill, DO
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics19 小时
Nathan Hitzeman, MD
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics19 小时
Tonya Chaffee, MD, MPH, Clinical Professor of Pediatrics, at the University of California ...
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics19 小时
Leah K. Middelberg, MD, FAAP
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics19 小时
Michelle Lai
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics19 小时
Catherine Y. Spong, MD
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics1 天
Atsuko Koyama, MD, MPH
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics1 天
Aimee Johnson, MD
A surprise mimicker of a rare disorder: 13-year-old female with altered mental status ...
contemporarypediatrics1 天
Lori D. Frasier, MD
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics1 天
Charles J. Hyman, MD, FAAP
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics1 天
Melissa Blaker, MD
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...